Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shuang Gao, Wencai Li, Guochao Lin, Guangrong Liu, Wenjuan Deng, Chuntao Zhai, Chunliang Bian, Gaiying He & Zhenlin Hu. (2016) Norisoboldine, an alkaloid from Radix linderae, inhibits NFAT activation and attenuates 2,4-dinitrofluorobenzene-induced dermatitis in mice. Immunopharmacology and Immunotoxicology 38:5, pages 327-333.
Read now
Read now
Margitta Worm. (2002) New compounds for the treatment of eczematous skin diseases. Expert Opinion on Therapeutic Patents 12:7, pages 1023-1033.
Read now
Read now
Articles from other publishers (37)
Mohammad Reza Afshar Mogaddam, Elnaz Marzi Khosrowshahi, Mir Ali Farajzadeh & Mahboob Nemati. (2023) CuBTC metal organic framework-based dispersive solid phase extraction of cyclosporine and tacrolimus from plasma samples prior to determination by high performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 1222, pages 123692.
Crossref
Crossref
Ankit Chaudhary, Mayank Patel & Shamsher Singh. (2022) Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo. Current Drug Targets 23:13, pages 1219-1238.
Crossref
Crossref
David Nguyen, Philippe-Henri Secrétan, Camille Cotteret, Emmanuelle Jacques-Gustave, Céline Greco, Christine Bodemer, Joel Schlatter & Salvatore Cisternino. (2022) Stability and Formulation of Erlotinib in Skin Creams. Molecules 27:3, pages 1070.
Crossref
Crossref
Junjiang Liu, Liran Shi, Xiangjian Wang, Fanglong Wu, Mingjia Hu, Jing He, Mei Lin, Hongmei Wang & Hongmei Zhou. (2020) Tacrolimus 0.03% ointment treatment in exfoliative cheilitis: A randomised controlled clinical trial and monitoring blood concentration. Journal of Oral Pathology & Medicine 50:2, pages 251-259.
Crossref
Crossref
. (2020) Chinese Guidelines for the Management of Chronic Pruritus (2018). International Journal of Dermatology and Venereology 3:1, pages 1-7.
Crossref
Crossref
Hiroshi ASHIGAI, Yuta KOMANO, Guanying WANG, Yasuji KAWACHI, Kazuko SUNAGA, Reiko YAMAMOTO, Ryoji TAKATA, Mika MIYAKE & Takaaki YANAI. (2018) Effect of administrating polysaccharide from black currant (<i>Ribes nigrum</i> L.) on atopic dermatitis in NC/Nga mice. Bioscience of Microbiota, Food and Health 37:1, pages 19-24.
Crossref
Crossref
Li Liang & Wei-Yun Shi. (2017) The effects of FK506 combined with natamycin in the treatment of experimental fungal keratitis by suppressing NLRP3 inflammasome activation. European Journal of Inflammation 15:3, pages 192-199.
Crossref
Crossref
Andreia Freire de Menezes, Fernanda Oliveira de Carvalho, Rosana S. S. Barreto, Bruno de Santana Silva, Saravanan Shanmugam, Ricardo Queiroz Gurgel & Adriano Antunes de Souza Araújo. (2017) Pharmacologic Treatment of Vitiligo in Children and Adolescents: A Systematic Review. Pediatric Dermatology 34:1, pages 13-24.
Crossref
Crossref
Hyejung Jung, Heesung Chung, Sung Eun Chang, Duk-Hee Kang & Eok-Soo Oh. (2016) FK506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes. Pigment Cell & Melanoma Research 29:2, pages 199-209.
Crossref
Crossref
K Kasutani, E Fujii, S Ohyama, H Adachi, M Hasegawa, H Kitamura & N Yamashita. (2014) Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. British Journal of Pharmacology, pages n/a-n/a.
Crossref
Crossref
Young Ji Lee, Sun Woong Kim & Kyoung Yul Seo. (2013) Application for Tacrolimus Ointment in Treating Refractory Inflammatory Ocular Surface Diseases. American Journal of Ophthalmology 155:5, pages 804-813.e1.
Crossref
Crossref
E S Fedenko, T M Filimonova, O G Elisyutina, O V Shtyrbul & D D Niyazov. (2012) Pathogenetic substantiation of an integrated approach to topical therapy of atopic dermatitis. Russian Journal of Allergy 9:4, pages 50-55.
Crossref
Crossref
Seung Keun Back, Keun-Yeong Jeong, Chengjin Li, Jaehee Lee, Sat-Byol Lee & Heung Sik Na. (2012) Chronically relapsing pruritic dermatitis in the rats treated as neonate with capsaicin; a potential rat model of human atopic dermatitis. Journal of Dermatological Science 67:2, pages 111-119.
Crossref
Crossref
Norikazu TAKANOYuki INOKUCHIMichio KURACHI. (2011) Effects of Ethanol Extracts of Herbal Medicines on Dermatitis in an Atopic Dermatitis Mouse Model生薬エキスのアトピー性皮膚炎モデルマウス皮膚炎症状に対する作用. YAKUGAKU ZASSHI 131:4, pages 581-586.
Crossref
Crossref
Eva D. Papadimitraki, George Bertsias, George Chamilos & Dimitrios T. Boumpas. 2011. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
1083
1108
.
A A KUBANOVA, D V PROSHUTINSKAYA, L V TEKUCHEVA & I N AVDIYENKO. (2010) Integral approach to the external therapy of atopic dermatitis. Vestnik dermatologii i venerologii 86:1, pages 20-26.
Crossref
Crossref
Bryden J. Stanley & Joe G. Hauptman. (2009) Long-term prospective evaluation of topically applied 0.1% tacrolimus ointment for treatment of perianal sinuses in dogs. Journal of the American Veterinary Medical Association 235:4, pages 397-404.
Crossref
Crossref
Christina STEFANAKI, Kalliopi STEFANAKI, George KONTOCHRISTOPOULOS, Christina ANTONIOU, Alexander STRATIGOS, Electra NICOLAIDOU, Stamatis GREGORIOU & Andreas KATSAMBAS. (2008) Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study. The Journal of Dermatology 35:11, pages 712-718.
Crossref
Crossref
Sibylle Schliemann, Daniela Kelterer, Andrea Bauer, Swen M. John, Christoph Skudlik, Ingo Schindera, Wolfgang Wehrmann & Peter Elsner. (2008) Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis 58:5, pages 299-306.
Crossref
Crossref
Thilo Gambichler, Axel Schlaffke, Nordwig S. Tomi, Nick Othlinghaus, Peter Altmeyer & Alexander Kreuter. (2008) Tacrolimus ointment neither blocks ultraviolet B nor affects expression of thymine dimers and p53 in human skin. Journal of Dermatological Science 50:2, pages 115-122.
Crossref
Crossref
N. Meykadeh, F. Meiss, W. C. Marsch & M. Fischer. (2007) Steroidaggravierte RosazeaSteroid-aggravated rosacea. Der Hautarzt 58:4, pages 338-342.
Crossref
Crossref
Iwao Arai, Akiko Takaoka, Yuki Hashimoto, Yusuke Honma, Chie Koizumi, Nobuko Futaki, Masanori Sugimoto, Nobutaka Takahashi, Tomoyuki Inoue, Yutaka Nakanishi, Takanobu Sakurai, Toru Tanami, Makoto Yagi, Naoya Ono & Shiro Nakaike. (2007) Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice. European Journal of Pharmacology 556:1-3, pages 207-214.
Crossref
Crossref
Thilo Gambichler, Nordwig S. Tomi, Georg Moussa, Julia Huyn, Heinrich Dickel, Peter Altmeyer & Alexander Kreuter. (2006) Topical tacrolimus neither prevents nor abolishes ultraviolet–induced erythema. Journal of the American Academy of Dermatology 55:5, pages 882-885.
Crossref
Crossref
Matthias Schneider, Rebecca Fischer-Betz, Kristina Gensch, Christof Iking-Konert & Annegret Kuhn. 2006. The Skin in Systemic Autoimmune Diseases. The Skin in Systemic Autoimmune Diseases
325
335
.
P. A. Gerber, N. J. Neumann, T. Ruzicka & D. Bruch-Gerharz. (2005) Periorale Dermatitis. Der Hautarzt 56:10, pages 967-968.
Crossref
Crossref
T-Y. Tzung & J-C. Wu. (2005) Topical calcineurin inhibitors in treating Jessner's lymphocytic infiltration of the skin: report of a case. British Journal of Dermatology 152:2, pages 383-384.
Crossref
Crossref
Dene Simpson & Stuart Noble. (2005) Tacrolimus Ointment. Drugs 65:6, pages 827-858.
Crossref
Crossref
Norikazu Takano, Takanobu Sakurai & Michio Kurachi. (2005) Effects of Anti-Nerve Growth Factor Antibody on Symptoms in the NC/Nga Mouse, an Atopic Dermatitis Model. Journal of Pharmacological Sciences 99:3, pages 277-286.
Crossref
Crossref
A. J. Kanwar, S. Dogra & D. Parsad. (2004) Topical tacrolimus for treatment of childhood vitiligo in Asians. Clinical and Experimental Dermatology 29:6, pages 589-592.
Crossref
Crossref
T. Assmann, J. Becker, T. Ruzicka & M. Megahed. (2004) Topical tacrolimus for oral cicatricial pemphigoid. Clinical and Experimental Dermatology 29:6, pages 674-676.
Crossref
Crossref
Iwao Arai, Norikazu Takano, Yuki Hashimoto, Nobuko Futaki, Masanori Sugimoto, Nobutaka Takahashi, Tomoyuki Inoue & Shiro Nakaike. (2004) Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. European Journal of Pharmacology 505:1-3, pages 229-235.
Crossref
Crossref
Norikazu Takano, Iwao Arai, Yuki Hashimoto & Michio Kurachi. (2004) Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice. European Journal of Pharmacology 495:2-3, pages 159-165.
Crossref
Crossref
John C. Davis & John H. Klippel. 2004. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
1273
1293
.
Indra D.M. Van Mourik & Celia Moss. 2003. Diseases of the Liver and Biliary System in Children. Diseases of the Liver and Biliary System in Children
300
312
.
Azin Meshkinpour, Joannie Sun & Gerald Weinstein. (2003) An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. Journal of the American Academy of Dermatology 49:1, pages 145-147.
Crossref
Crossref
Suzan Artik & Thomas Ruzicka. (2003) Complementary therapy for atopic eczema and other allergic skin diseases. Dermatologic Therapy 16:2, pages 150-163.
Crossref
Crossref
Norikazu Takano, Iwao Arai & Michio Kurachi. (2003) Analysis of the spontaneous scratching behavior by NC/Nga mice: a possible approach to evaluate antipruritics for subjects with atopic dermatitis. European Journal of Pharmacology 471:3, pages 223-228.
Crossref
Crossref